Daily non-political popular news in brief.

LCT reports major step forward for islet transplantation in diabetes patient

Living Cell Technologies has published evidence outlining the survival and identification of live porcine islet cells and insulin production in a human patient with diabetes 10 years after he received a micro-encapuslated pig islet cell transplant. The paper outlines how LCT has demonstrated the long-term safety, viability and function of its encapsulated porcine islets in a human patient over an extended period of time, without the use of immunosuppression.

Read more »

Keywords: lct, reports, major, step, forward, islet, transplantation, diabetes, patient, report, diabete

« Previous | Next »

Similar news on "LCT reports major step forward for islet transplantation in diabetes patient":

1. Stanford study finds transplant patient thrives 2 years after stopping immunosuppressive drugs
   01-23-2008 · EurekAlert!
   Stanford researchers describe a patient's case in a brief report to be published in the Jan. 24 issue of The New England Journal of Medicine on the technique they developed, based on 25 years of research by Samuel Strober, MD, professor of immunology and rheumatology. The journal issue also includes two reports from other research groups, describing their efforts to achieve organ transplantation without long-term immunosuppressive drugs.
   Similar news · Read more »
   
2. Department of Energy Advances NSLS-II Project
   07-17-2007 · Brookhaven National Laboratory
   The Department of Energy (DOE) has granted "Critical Decision 1" (CD-1) status to the National Synchrotron Light Source-II (NSLS-II). This decision, which assures the facility's location at DOE's Brookhaven National Laboratory, is a major step forward in the long process to make this state-of-the-art research complex a reality. The world leading capabilities of NSLS-II will enable exploration of the scientific challenges faced in developing new materials with advanced properties.
   Similar news · Read more »
   
3. Breakthrough research identifies how cells from pigs may cure diabetes
   09-12-2007 · EurekAlert!
   On Thursday, Sept. 20, at 10 a.m. CDT, Dr. Bernhard Hering, scientific director of the Diabetes Institute for Immunology & Transplantation at the University of Minnesota will present the latest research on pig islet xenotransplantation at the Diabetes Research and Wellness Foundation Symposium at the Hyatt Regency Minneapolis in Minneapolis, Minn.
   Similar news · Read more »
   
4. The new source of islet cells
   10-25-2007 · EurekAlert!
   Islets transplantation is one promising approach to type 1 diabetes treatment, but it is limited by the shortage of islet cells. Dr Liu et al. found a new approach which can produce more islet cells.
   Similar news · Read more »
   
5. UCLA, Caltech chemists report important step toward building molecular computers
   01-24-2007 · EurekAlert!
   A team of UCLA and Caltech chemists reports in the January 25 issue of the journal Nature the successful demonstration of a large-scale (160 kilobit) memory device that stores information using reconfigurable molecular switches. This research represents an important step toward the creation of molecular computers that are much smaller and could be more powerful than today's silicon-based computers.
   Similar news · Read more »
   
6. Immunosuppressive drugs are a double-edged sword to type 1 diabetics
   09-04-2007 · EurekAlert!
   Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
   Similar news · Read more »
   
7. FDA Nanotechnology Task Force takes positive step forward
   07-25-2007 · EurekAlert!
   Today’s report from the Food and Drug Administration (FDA) Nanotechnology Task Force is an important and positive step forward in the agency’s effort to tackle the new scientific and regulatory challenges posed by nanotechnology. The Task Force is clear and candid in acknowledging the pervasive potential of nanotechnology to affect virtually every product category FDA regulates -- from pharmaceuticals and devices to cosmetics and food supplements -- and in calling for a wide range of FDA actions to prepare for and execute its oversight role.
   Similar news · Read more »
   
8. UW paper in Science shows how some solids mimic liquids on nanoscale
   02-01-2008 · EurekAlert!
   A University of Waterloo physics and astronomy research team, in a paper to be published Feb. 1 in Science, shows how some solids behave like liquids on the nanoscale. The UW researchers, professor James Forrest and then-graduate student Zahra Fakhraai, take a major step forward in discovering how to measure polymer substances using nanoscale technology. They explore the properties of the large class of natural and synthetic materials on the nanoscale.
   Similar news · Read more »
   
9. A step toward tissue-engineered heart structures for children
   09-12-2007 · EurekAlert!
   Infants and children receiving artificial heart-valve replacements face several repeat operations as they grow, since the since the replacements become too small and must be traded for bigger ones. Researchers at Children's Hospital Boston have now developed a solution: living, growing valves created in the lab from a patient's own cells. In a report in Circulation: Journal of the American Heart Association, published Sept. 11, they describe making pulmonary valves through tissue engineering.
   Similar news · Read more »
   
10. Living donors may be best source of insulin-producing islets for diabetes treatment
    11-26-2007 · EurekAlert!
    According to a new study in Clinical Transplantation, obtaining islet cells (clusters of pancreatic cells that create insulin) from living donors may be a solution to the shortage of islets available for transplantation. In samples taken from living donors, 94 percent of the cells were viable for transplant, compared to only 42 percent of cells taken from deceased donors.
    Similar news · Read more »